NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead ...
Q1 2026
May 18, 2026
FY 2025
Mar 31, 2026
Q4 2025
Q3 2025
Nov 25, 2025
Q2 2025
Aug 27, 2025